Bob Montgomery completed a 5,300-kilometre ride across Australia on Sunday. He was dead by Monday night.
The 82-year-old Bowral man, who'd spent over a decade raising money for motor neurone disease research after his cousin died 12 years ago, experienced a medical episode while travelling home from a celebration of his final ride. His death—unexpected but peaceful, according to his wife of 59 years, Jen—came just hours after he'd been surrounded by family, friends, and supporters at a homecoming function in Sydney's Rose Bay.
"It was just an amazing afternoon," Montgomery told ABC Illawarra Drive on Monday morning, still processing the community's response to his six-week "One Last Ride" journey from Broome in Western Australia to his hometown. He didn't know he had hours left.
Montgomery's death underscores both the devastating reach of motor neurone disease and the power of individual commitment to collective action. His five charity rides raised more than $300,000 for MND research and service support—resources that matter enormously when public health funding for rare diseases remains chronically limited.
A Life Devoted to Advocacy
Montgomery wasn't a celebrity or a politician. He was an ordinary man who chose to act after personal loss. His cousin's death 12 years ago catalyzed a commitment that defined the final chapter of his life. He didn't have to do any of this. He chose to do it.
His latest ride, which covered almost 5,300 kilometres, drew support from across the country. When he and his 18-year-old grandson, Tom Malcolm, reached Bowral on Sunday, dozens of family members, friends, and wellwishers welcomed them home. The gathering included Jai Arrow, the former South Sydney Rabbitohs player and MND sufferer, whose presence spoke to the community Montgomery had helped build around the disease.
MND NSW chief executive Liam O'Meara watched Montgomery's final celebration unfold. "Tom decided to push the extra 150-odd kilometres from Bowral to Sydney yesterday and we all got together to greet him," O'Meara said. "It was a lovely afternoon."
Montgomery described the event in his last public interview: "They put on a fantastic feed and the speeches were wonderful. It was very memorable, for sure."
The Burden Falls on Communities
Motor neurone disease is a rare condition. That rarity means it doesn't command the research funding or media attention that more common diseases receive. The $300,000 Montgomery raised through his own physical effort represents a gap—the distance between what public institutions allocate and what patients and families actually need.
O'Meara acknowledged this reality without bitterness, focusing instead on what Montgomery's commitment revealed: "It can't be understated what he has achieved for many years, not just on this ride. He's been a massive advocate and stalwart for the MND community."
The family released a statement calling Montgomery a "beautiful soul" and expressing gratitude for the "kindness, love and messages of support" that surrounded him in his final days. His wife emphasized that his last few days on earth were among the best—a small mercy, perhaps, but one that mattered.
Moving Forward
MND NSW is now planning a posthumous accolade for Montgomery and looking to establish a memorial ride in his honour. "He absolutely deserves it and we want to honour his memory," O'Meara said.
The organization faces a choice that reflects a broader challenge: whether to treat Montgomery's legacy as a touching individual story, or as evidence of a structural gap. Rare diseases rely disproportionately on volunteer fundraisers and individual advocates. That's admirable. It's also a reminder that public health systems depend on people like Montgomery to fill holes that should be filled through democratic allocation of resources.
Montgomery won't be here to see what comes next. But the $90,000 still coming in from his final ride will fund research and services. His grandson Tom will remember pushing those extra 150 kilometres. His wife will remember his last 48 hours as some of his best.
Why This Matters:
Montgomery's death highlights the reality that rare disease research and support services depend heavily on individual charity rather than consistent public funding. His five rides raised over $300,000—resources that should arguably come through coordinated health systems rather than requiring an 82-year-old man to cycle 5,300 kilometres. The fact that someone must choose between personal sacrifice and seeing their community's disease get adequate attention reflects a gap in how we collectively fund health research. Montgomery's commitment was extraordinary. That it was necessary at all suggests a system that asks too much of individuals and too little of institutions. His legacy will include not just the money raised, but the question of whether rare diseases deserve better than relying on the goodwill of aging advocates.